PET Scans (Positron Emission Tomography)
Positron Emission Tomography (PET) is a method of scanning the body for tumors. It uses a machine capable of detecting gamma rays – a type of radiation – and uses these rays to locate cancerous cells.
When a patient has a PET scan, he or she will be injected with radioactive glucose (a sugar). Glucose injected into the veins will circulate through the body quickly and be absorbed into the cells that need the most energy. Since cancer cells grow faster and demand more nourishment than any other cell in the body, tumors will absorb the majority of the radioactive glucose.
This glucose emits positrons (positive electrons) as the radioactive molecule attached to it breaks down. These positrons collide with electrons in the body. When this happens, a gamma ray is created.
The patient lies down on a table inside a machine that looks a lot like an MRI machine. The PET machine detects the gamma rays and locates the origin of the radiation, thus locating a tumor in the body. This information is used in conjunction with a CT scan or X-ray so that doctors can identify the location of all of the patient’s tumors.
Side Effects
Though a PET scan has very few side effects, the radioactive isotope will stay in your body for 24-48 hours. For this reason, it is recommended that you avoid contact with anyone for a day so that you don’t expose anyone to the radiation.
Similar Tests
MRIs, CT scans, X-rays, and gallium scans can also be used to identify and locate tumors.
For more information on Hodgkin's Disease, please see the following pages:
- Adult Hodgkin's Lymphoma: Diagnosis
- Adult Hodgkin's Lymphoma: Treatment
- Adult Hodgkin's Lymphoma: Introduction
- Childhood Hodgkin's Lymphoma: Diagnosis
- Childhood Hodgkin's Lymphoma: Treatment
- Childhood Hodgkin's Lymphoma: Introduction
For more information on Non-Hodgkin Lymphoma, please see the following pages:
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
